Ligand id: 2031

Name: lanreotide

Structure and Physico-chemical Properties

2D Structure
1. Bruns C, Raulf F, Hoyer D, Schloos J, Lubbert H, Weckbecker G. (1996)
Binding properties of somatostatin receptor subtypes.
Metabolism, 45: 17-20. [PMID:8769372]
2. Meyerhof W. (1998)
The elucidation of somatostatin receptor functions: a current view.
Rev Physiol Biochem Pharmacol, 133: 55-108. [PMID:9600011]
3. Patel YC, Srikant CB. (1994)
Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5).
Endocrinology, 135: 2814-2817. [PMID:7988476]
4. Raynor K, Murphy WA, Coy DH, Taylor JE, Moreau JP, Yasuda K, Bell GI, Reisine T. (1993)
Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Mol Pharmacol, 43: 838-844. [PMID:8100350]
5. Siehler S, Seuwen K, Hoyer D. (1998)
[125I]Tyr10-cortistatin14 labels all five somatostatin receptors.
Naunyn Schmiedebergs Arch Pharmacol, 357: 483-489. [PMID:9650799]
6. Siehler S, Seuwen K, Hoyer D. (1998)
[125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
Eur J Pharmacol, 348: 311-320. [PMID:9652348]
7. Siehler S, Seuwen K, Hoyer D. (1999)
Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies.
Naunyn Schmiedebergs Arch Pharmacol, 360: 488-499. [PMID:10598788]